Executive Committee: Virax Biolabs Group Limited

Manager
Positions heldSince
James Foster

James Foster

40 year

Comptroller/Controller/Auditor -
Chief Executive Officer 31/12/2012
Nigel McCracken

Nigel McCracken

61 year

Chief Operating Officer 31/08/2023

Composition of the Board of Directors: Virax Biolabs Group Limited

Director
CommitteesSince
James Foster

James Foster

40 year

Chairman 31/12/2012
Nelson Haight

Nelson Haight

61 year

Audit Committee 07/04/2021
Compensation Committee
Governance Committee
Nominating Committee
Audit Committee Chair
Evan Norton

Evan Norton

51 year

Audit Committee
Compensation Committee
Governance Committee Chair
Nominating Committee Chair
Nigel McCracken

Nigel McCracken

61 year

Director/Board Member
Iain Miller

Iain Miller

Director/Board Member 28/07/2025
Independent Dir/Board Member 28/07/2025

Former Officers and Directors: Virax Biolabs Group Limited

Insider
Positions held
SinceUntil
Yair Erez
Yair Erez
Director/Board Member - 28/07/2025
Independent Dir/Board Member - 28/07/2025
Jason Davis
Jason Davis
Director of Finance/CFO 28/02/2022 31/05/2025
Mark Ternouth
Mark Ternouth
Director/Board Member 31/08/2023 10/06/2024
Chief Tech/Sci/R&D Officer - 10/06/2024
Tomasz George
Tomasz George
Chief Tech/Sci/R&D Officer 31/01/2021 15/04/2024
Cameron Shaw
Cameron Shaw
Director/Board Member 31/12/2012 31/08/2023
Chief Operating Officer 31/12/2012 31/08/2023
Founder 31/12/2012 31/08/2023
Margaret Gilmour
Margaret Gilmour
Director/Board Member - -
Independent Dir/Board Member - -

Age distribution of managers

Parity Men Women

Male5
Female0

Of which Executive Committee

Male2
Female0

Of which Directors

Male5
Female0
Logo Virax Biolabs Group Limited
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against global viral threats. Its product portfolio includes ViraxClear and Virax Immune. ViraxClear offers a range of accurate diagnostic testing kits and machines. Virax Immune is a new Covid-19 test seeking detection of T-Cell immune responses to the SARS-Cov-2 virus. Its T-Cell testing is effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Monkeypox, Hepatitis B, Malaria, Herpes and Human Papillomavirus.
Employees
19
More about the company